Upadacitinib for Rheumatoid Arthritis User Reviews (Page 5)
Brand names: Rinvoq, Rinvoq LQ
Upadacitinib has an average rating of 6.4 out of 10 from a total of 99 reviews for the treatment of Rheumatoid Arthritis. 49% of reviewers reported a positive experience, while 29% reported a negative experience.
Reviews for Upadacitinib
- Lac
- Taken for 1 to 6 months
- April 12, 2021
"I was on Rinvog for 2 months and had to go off because my white blood cells dropped to low. I do not believe it was working for me anyways."
- lisa
- Taken for 1 to 6 months
- June 10, 2024
Rinvoq (upadacitinib) "I've been taking Rinvoq for a few weeks. At first, it was okay, but now I have blisters in my mouth. I cannot eat. I don't know what's going on."
Frequently asked questions
- What are the most common skin conditions? (with photos)
- What are the new drugs for rheumatoid arthritis (RA)?
- What is the MOA and half-life for Rinvoq?
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Rheumatoid Arthritis
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about upadacitinib
- Check interactions
- Compare alternatives
- Reviews (184)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Rinvoq (upadacitinib) "Works well but caused acne on face, extreme tiredness, frequent urination, massive eye bags"